Eric Blasius Risser - Oct 28, 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Chief Operating Officer
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Stock symbol
MGNX
Transactions as of
Oct 28, 2022
Transactions value $
$0
Form type
4
Date filed
10/31/2022, 04:36 PM
Previous filing
Mar 4, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $12.8K +8.5K +18.9% $1.51 53.5K Oct 28, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Employee stock option (right to buy) Options Exercise -$12.8K -8.5K -100% $1.51 0 Oct 28, 2022 Common Stock 8.5K $1.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.